Global Aortic Aneurysm Market Size By Type (Medicine, Surgery), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Aortic Aneurysm Market was valued at USD 3.4 billion in 2023 and is expected to reach USD 6.7 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2023–2031). Growth is driven by the increasing prevalence of aortic aneurysms, the aging population, advancements in minimally invasive surgical techniques, and greater awareness and diagnosis rates. Aortic aneurysms—enlargements of the aorta—pose serious risks if ruptured, necessitating timely intervention and treatment, which fuels demand for diagnostic tools and therapeutic procedures.

Drivers

Rising Incidence of Aortic Aneurysms:

Aging demographics and lifestyle-related risk factors such as hypertension, smoking, and high cholesterol are contributing to a growing patient base. With cardiovascular conditions on the rise globally, the diagnosis and management of aortic aneurysms have become a healthcare priority.

Technological Advancements in Endovascular Repair (EVAR):

Minimally invasive approaches like EVAR are gaining traction due to shorter recovery times, reduced hospital stays, and fewer complications compared to open surgery. Innovations in stent graft design and imaging techniques are further enhancing procedural success rates.

Improved Diagnostic Imaging Techniques:

Increased utilization of advanced imaging technologies such as CT angiography and MR angiography facilitates early diagnosis, leading to improved clinical outcomes and heightened demand for related medical devices.

Restraints

High Cost of Treatment and Devices:

The cost of endovascular devices and surgical procedures remains high, especially in low- and middle-income countries. Limited reimbursement policies in some regions can restrict patient access to effective treatments.

Stringent Regulatory Approvals:

The development and approval of new stent grafts and surgical tools face rigorous regulatory processes, which can slow down innovation and market entry for novel solutions.

Opportunities

Emerging Economies and Healthcare Infrastructure Development:

Countries in Asia-Pacific and Latin America are investing heavily in healthcare infrastructure, creating potential for market penetration, particularly through public-private partnerships and government-sponsored screening programs.

Growing Demand for Personalized Medicine:

Tailored therapeutic strategies based on genetic profiling and patient-specific factors are expected to revolutionize aortic aneurysm treatment, presenting new opportunities for product development and service differentiation.

Market by System Type Insights

By system type, the Thoracic Aortic Aneurysm (TAA) segment held the largest share in 2023 due to its high fatality risk and the increasing availability of advanced surgical procedures. However, the Abdominal Aortic Aneurysm (AAA) segment is projected to witness the fastest growth, attributed to rising lifestyle-related disorders, high smoking prevalence, and the growing availability of EVAR procedures in both urban and rural healthcare settings.

Market by End-Use Insights

The Hospitals segment dominated the market in 2023, driven by the availability of advanced surgical infrastructure and skilled healthcare professionals. Specialized hospitals with dedicated vascular surgery departments are increasingly performing aortic aneurysm repairs. Meanwhile, Ambulatory Surgical Centers (ASCs) are gaining popularity due to cost-effectiveness and shorter patient stays, supporting market growth in outpatient settings.

Market by Regional Insights

North America led the global market in 2023, driven by a high prevalence of cardiovascular diseases, strong reimbursement frameworks, and a robust healthcare system. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period due to rapid urbanization, healthcare reforms, and increasing awareness of aneurysm risks. Countries like China, India, and Japan are major contributors to regional growth.

Competitive Scenario

Key players in the Global Aortic Aneurysm Market include:

Medtronic plc

Cook Medical

Terumo Corporation

Cardinal Health

Boston Scientific Corporation

Endologix LLC

MicroPort Scientific Corporation

CryoLife Inc.

Abbott Laboratories

W. L. Gore & Associates

These companies are focusing on product innovations, regulatory approvals, strategic acquisitions, and regional expansions to strengthen their market presence. For example:

In 2023, Medtronic received FDA approval for its next-generation endograft designed for complex aneurysm anatomies.

Terumo Corporation launched a new thoracic stent graft system targeting minimally invasive aortic repair in 2024.

Boston Scientific expanded its EVAR product line with a novel low-profile delivery system to address anatomical challenges in 2025.

Scope of Work – Global Aortic Aneurysm Market

Report Metric Details

Market Size (2023) USD 3.4 billion

Projected Market Size (2031) USD 6.7 billion

CAGR (2023–2031) 8.7%

Market Segments By System Type (TAA, AAA), End-Use, Region

Growth Drivers Aging population, Technological advancements

Opportunities Emerging markets, Personalized medicine

Key Market Developments

2023: Medtronic launched a new aortic stent graft system with improved sealing capabilities for better long-term outcomes.

2024: Endologix announced CE Mark approval for its novel polymer-based endograft system, enhancing aneurysm sealing in challenging cases.

2025: Cook Medical partnered with a major European research center to develop AI-assisted preoperative planning tools for EVAR procedures.

FAQs

What is the current market size of the Global Aortic Aneurysm Market?

The market was valued at USD 3.4 billion in 2023.

What is the major growth driver of the Global Aortic Aneurysm Market?

The major driver is the rising incidence of aortic aneurysms and advancements in minimally invasive surgical techniques.

Which is the largest region during the forecast period in the Global Aortic Aneurysm Market?

North America is projected to remain the largest regional market through 2031.

Which segment accounted for the largest market share in the Global Aortic Aneurysm Market?

The Thoracic Aortic Aneurysm (TAA) segment held the largest share in 2023.

Who are the key market players in the Global Aortic Aneurysm Market?

Key players include Medtronic, Cook Medical, Terumo, Cardinal Health, and Boston Scientific.